News and actuality

Current press releases, talks and reports

Researchers from the University of Cologne and NEO New Oncology AG publish new findings on the importance of thorough molecular diagnosis in cancer

Read more

Cologne, October 9, 2015 – NEO New Oncology AG, a Cologne based cancer diagnostics company, today announced the closing of a financing round with a total investment of app. EUR 5 Million.

“I am pleased by the strong interest that NEO New Oncology AG has received from the...

Read more

Cologne, September 7, 2015 – New Oncology today announced that an abstract highlighting the company's progress in clinical cancer genome diagnostics will be presented at the 16th World Conference on Lung Cancer taking place September 6 – 9, 2015, in Denver, USA.

Date & Time: Wedn...

Read more

Cologne, March 17, 2015 – New Oncology today announced the completion of a financing round to prepare the market launch of NEOliquid, a non-invasive blood test that identifies therapeutically actionable genome alterations in the circulating free tumour DNA (ctDNA) of cancer...

Read more

Cologne, January 22, 2015 – New Oncology and the University Hospital Oslo announced today that they have entered into a collaboration to identify alterations in cancer-related tumour genes that predict a patient’s response or resistance to targeted therapies.
Under this agreement,...

Read more



Office: +49.221.888.23 80

Download/More information

Information for specialists


NEO New Oncology GmbH
Gottfried-Hagen-Str. 20
51105 Cologne

ImprintPrivacy policy is using cookies in order to optimize the user experience on our website. By using this site you agree to the use of cookies.